A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer

Hallmarks of Cancer: New Dimensions

(2022) Douglas Hanahan   Cancer Discovery

Comprehensive Evaluation of Machine Learning Models and Gene Expression Signatures for Prostate Cancer Prognosis Using Large Population Cohorts

(2022) Ruidong Li et al.   CANCER RESEARCH

NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition

(2022) Sepideh Mirzaei et al.   JOURNAL OF CELLULAR PHYSIOLOGY

PFKL, a novel regulatory node for NOX2-dependent oxidative burst and NETosis

(2022) Zhaohui Cao et al.   Journal of Zhejiang University-SCIENCE B

Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1

(2022) Jack Lawler   SEMINARS IN CANCER BIOLOGY

Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target

(2022) Enrique A. Castellón et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy

(2021) Alexander Bagaev et al.   CANCER CELL

Selective activation of PFKL suppresses the phagocytic oxidative burst

(2021) Neri Amara et al.   CELL

m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer

(2020) Huilin Huang et al.   CANCER CELL

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

(2020) David A. Braun et al.   NATURE MEDICINE

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer

(2020) Philip Cornford et al.   EUROPEAN UROLOGY

MODOMICS: a database of RNA modification pathways. 2017 update

(2017) Pietro Boccaletto et al.   NUCLEIC ACIDS RESEARCH

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

(2017) Martin Lauss et al.   Nature Communications

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy

(2017) Shuang G. Zhao et al.   JAMA Oncology

Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-κB inflammatory pathway

(2016) Selvi Ramasamy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

(2014) Eric A. Klein et al.   EUROPEAN UROLOGY

Gene expression regulation mediated through reversible m6A RNA methylation

(2014) Ye Fu et al.   NATURE REVIEWS GENETICS

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

(2014) Alexandra Snyder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development and validation of a 32-gene prognostic index for prostate cancer progression

(2013) C.-L. Wu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

mRNA Expression Signature of Gleason Grade Predicts Lethal Prostate Cancer

(2011) Kathryn L. Penney et al.   JOURNAL OF CLINICAL ONCOLOGY